节点文献

三七皂苷R1保护四氯化碳诱导肝纤维化模型大鼠的作用

Protective effect of notoginsenoside R1 on carbon tetrachloride-induced liver fibrosis in rats

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴朕马微臧成昊刘矿嫔刘伟刘洁梁宇李春艳陈志明茹金樊楚明杨金伟郭建辉李力燕

【Author】 Wu Zhen;Ma Wei;Zang Chenghao;Liu Kuangpin;Liu Wei;Liu Jie;Liang Yu;Li Chunyan;Chen Zhiming;Ru Jin;Fan Chuming;Yang Jinwei;Guo Jianhui;Li Liyan;The Affiliated Hospital of Kunming University of Science and Technology, the First People’s Hospital of Yunnan Province;Kunming Medical University;

【通讯作者】 杨金伟;郭建辉;李力燕;

【机构】 昆明理工大学附属医院云南省第一人民医院昆明医科大学

【摘要】 背景:前期研究发现,三七总皂苷对小鼠免疫性肝损伤具有一定的保护作用。目的:探究三七皂苷R1对四氯化碳诱导的肝纤维化模型大鼠的治疗作用。方法:用四氯化碳诱导SD雄性大鼠制备肝纤维化模型,给药组按照60 mg/kg的剂量给予30 g/L三七皂苷R1溶液,1次/d,连续4周和6周。对照组及模型组给予同体积的生理盐水,采用苏木精-伊红染色及Masson染色观察肝脏组织结构和纤维化程度分期;反转录-定量聚合酶链反应(q RT-PCR)检测法检测Ⅰ型胶原、α-平滑肌激动蛋白和转化生长因子β1表达水平。实验方案经昆明医科大学动物实验伦理委员会批准(批准号为approval No. KMMU2018018)。结果与结论:(1)肝组织病理学显示,与模型组相比,三七皂苷R1能显著减轻纤维增生程度;(2)与模型组相比,三七皂苷R1组Ⅰ型胶原、α-平滑肌激动蛋白和转化生长因子β1表达水平显著降低(P <0.05),三七皂苷R1给药4周与6周组比较差异无显著性意义;(3)结果提示,三七皂苷R1对四氯化碳诱导的肝纤维化模型大鼠具有一定的治疗作用。

【Abstract】 BACKGROUND: Previous studies have found that panax notoginseng saponins have a certain protective effect on immunological liver injury in mice. OBJECTIVE: To explore the therapeutic effect of notoginsenoside R1 on carbon tetrachloride-induced liver fibrosis in rats. METHODS: Experimental liver fibrosis model was made by carbon tetrachloride in male Sprague-Dawley rats. Then 30 g/L notoginsenoside R1(60 mg/kg) was given once daily for 4 and 6 weeks in the treatment group. Rats in the control and model group were given distilled water of the same volume. Histopathological observation with hematoxylin-eosin staining and Masson’s trichrome staining was used to evaluate the changes of liver structure and fibrosis degree. The expression of collage type I, α-smooth muscle actin and transforming growth factor-β1 mRNA of hepatic tissue was measured by qRT-PCR method. The experimental protocol was approved by the Animal Experiment Ethics Committee of Kunming Medical University(approval No. KMMU2018018). RESULTS AND CONCLUSION: Liver histopathology showed that notoginsenoside R1 improved the degree of liver fibrosis. The expression levels of collagen type I, α-smooth muscle actin and transforming growth factor-β1 mRNA were reduced significantly in the treatment group compared with the model group(P < 0.05). But there was no significant difference after 4 and 6 weeks of treatment with notoginsenoside R1. Overall findings indicate that notoginsenoside R1 can slow down the progression of carbon tetrachloride-induced liver fibrosis in rats to a certain extent.

【基金】 国家自然科学基金项目(31560295),项目负责人:李力燕;云南省科技厅昆明医科大学联合专项重点项目[2018FE001(-163)],项目负责人:李力燕;云南省科技厅昆明医科大学联合专项重点项目[2019FE001(-179)],项目负责人:樊楚明;云南省心血管疾病影像研究中心(2017NS254,2018NS0270),项目负责人:陈志明;云南省创新团队(2019HC022),项目负责人:李力燕;云南省万人计划(YNWR-MY-2018-015),项目负责人:郭建辉;昆明医科大学重大科技成果培育项目(CGPY201802),项目负责人:李力燕~~
  • 【文献出处】 中国组织工程研究 ,Chinese Journal of Tissue Engineering Research , 编辑部邮箱 ,2020年26期
  • 【分类号】R285.5
  • 【被引频次】12
  • 【下载频次】478
节点文献中: 

本文链接的文献网络图示:

本文的引文网络